Description
Join HealthHIV for a 75-minute live webinar featuring two experts who will discuss the unique challenges, opportunities, and strategies for outreach and engagement of people experiencing homelessness (PEH) in PrEP services. This is the second webinar in a two-part series “PrEP for People Experiencing Homelessness: From Outreach to Adherence” that aims to educate healthcare professionals on delivering equitable and individualized PrEP care to PEH.
Faculty:
Sarah E. Rowan, MD
Associate Professor of Medicine
University of Colorado, School of Medicine
Denver, CO
Lauren Banks, MFA, M.Div
Executive Director
National HIV/AIDS Housing Coalition
Washington, D.C.
Release Date: January 25, 2024
Expiration Date: January 25, 2025
UAN#: JA0007322-9999-24-015-H01-P
Target Audience
HIV care providers, primary care providers, pharmacists, nurses, nurse practitioners, physician associates, social workers, and other healthcare professionals in primary care, HIV care, and STD clinic settings involved in the care of patients living with and at risk for HIV.- Media: Enduring Material
- Release date: January 25, 2024
- Expiration date: January 25, 2025
- Time to Complete: 75 minutes
Educational Objectives
After participating in the activity, the learners are expected to be better able to:
- Identify structural barriers people experiencing homelessness (PEH) face to initiating and adhering to PrEP
- Summarize care models to reduce barriers to PrEP, such as mobile healthcare, street medicine, and pharmacy services
- Construct an interdisciplinary care team approach that includes partnerships with social support services to support PEH in PrEP care
Accreditation, Credit, and Support
1.25 credits/contact hours is available for completion of this on-demand activity for physicians, physician associates, nurses, social workers, and pharmacists.
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and HealthHIV. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This program has been supported by an independent educational grant from Gilead Sciences, Inc.
Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.MOC Statement
Successful completion of this CME activity, which includes
participation in the evaluation component, enables the participant to earn up to 1.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit
participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation information will be shared through the ACCME's Program and Activity Reporting System (PARS).
ECMEC® Credit
The European Union of Medical Specialists-European
Accreditation Council for Continuing Medical Education (UEMS-EACCME®) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting
AMA PRA Category 1 Credit(s)TM into European CME credit (ECMEC®) should contact the UEMS (www.uems.eu).
Physician Associate Credit Designation Statement
Medical Learning Institute, Inc. has been authorized by the American
Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until January 25, 2025. PAs should only claim
credit commensurate with the extent of their participation.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 1.25 contact hours and no pharmacology contact hours.Continuing Pharmacy Education
Medical Learning Institute, Inc. designates this continuing education activity for 1.25 contact hours (0.125 CEUs) of the Accreditation Council for Pharmacy Education. Type of Activity: Knowledge. UAN: JA0007322-9999-24-015-H01-PSocial Worker Continuing Education
As a Jointly Accredited Organization, Medical Learning Institute, Inc. (MLI) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. Regulatory boards have the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.25 general continuing education credits.
Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team,
and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credits for learning and change.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider, and HealthHIV, the joint provider, do not have any relevant financial relationships to disclose with ineligible companies.Disclosure & Conflict of Interest Policy
Medical Learning Institute, Inc. and HealthHIV are committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your Board Unique ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit (75% is required for ABS).
For Pharmacists, MLI will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
Medical Learning Institute, Inc. and HealthHIV are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute, Inc. and HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters
Description:
During the 60-minute webinar, two experts will discuss the unique challenges, opportunities, and strategies for outreach and engagement of people experiencing homelessness (PEH) in PrEP services. The experts will share model practices, highlight patient case examples, and discuss strategies for engaging PEH in PrEP, such as PrEP medication adherence and persistence, adherence to medical appointments, and addressing common comorbidities.
Faculty:
Monica Gandhi MD, MPH
Director, UCSF-Bay Area CFAR
Professor, UCSF School of Medicine
San Francisco, CA
Patrick Ingram, MHSA
Community Health Specialist
PrEP Coordinator, The Red Door Clinic
Minneapolis, MN
Release Date: December 8, 2023
Expiration Date: December 8, 2024
UAN#: JA0007322-9999-23-119-H01-P
Target Audience
HIV care providers, primary care providers, nurse practitioners, physician associates, other clinicians, and other healthcare professionals in primary care, HIV care, and STD clinic settings involved in the care of patients living with and at risk for HIV.- Media: Enduring Material
- Release date: December 8, 2023
- Expiration date: December 8, 2024
- Time to Complete: 1 hour
Educational Objectives
After participating in the activity, the learners are expected to be better able to:
- Describe barriers people experiencing homelessness (PEH) face to initiating and adhering to PrEP and how providers and navigators can address these challenges.
- Identify culturally competent strategies and messaging for engaging PEH in PrEP.
- Summarize best practices for providing support to initiate PrEP, such as access to PrEP medication, labs and clinic visits for people experiencing homelessness (PEH).
- Identify collaborative strategies for interdisciplinary teams to guide PEH in their use of PrEP.
Accreditation, Credit, and Support
1.0 credit/contact hour is available for completion of this on-demand activity for physicians, physician associates, nurses, social workers, and pharmacists.
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and HealthHIV. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This program has been supported by an independent educational grant from Gilead Sciences, Inc.
Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.MOC Statement
Successful completion of this CME activity, which includes
participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit
participant completion information to ACCME for the purpose of granting ABIM MOC credit.Participation information will be shared through the ACCME's Program and Activity Reporting System (PARS).
ECMEC® Credit
The European Union of Medical Specialists-European
Accreditation Council for Continuing Medical Education (UEMS-EACCME®) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 Credit(s)TM into European CME credit (ECMEC®) should contact the UEMS (www.uems.eu).
Physician Associate Credit Designation Statement
Medical Learning Institute, Inc. has been authorized by the American
Academy of PAs (AAPA) to award AAPA Category 1.0 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until December 8, 2024. PAs should only claim
credit commensurate with the extent of their participation.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour and no pharmacology contact hour.Continuing Pharmacy Education
Medical Learning Institute, Inc. designates this continuing education activity for 1.0 contact hour (0.10 CEU) of the Accreditation Council for Pharmacy Education. Type of Activity: Knowledge. UAN: JA0007322-9999-23-119-H01-PInterprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team,
and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Social Worker Continuing Education
As a Jointly Accredited Organization, Medical Learning Institute,
Inc. (MLI) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. Regulatory boards
have the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.0 general continuing education credit.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider, and HealthHIV, the joint provider, do not have any relevant financial relationships to disclose with ineligible companies.Disclosure & Conflict of Interest Policy
Medical Learning Institute, Inc. and HealthHIV are committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your Board Unique ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit (75% is required for ABS).
For Pharmacists, MLI will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
Medical Learning Institute, Inc. and HealthHIV are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute, Inc. and HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters